Tags |
|
|
Links |
|
|
Subjects - Hiding Behind Numbers in Modern Corporations
Have you ever noticed how companies hide behind their accounting minutia? Using various accounting rules to hide the fact they are not making m
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
oney, only burning thru capital? Many a company executive will talk about how well the company is doing never will the utter a single negative
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
omment, which might hurt their stock. How can they do this? Well, it is easy the government regulators have made regulations so complex that th
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ere is so much they can hide behind that it is hard to tell what is going on, in fact the often fool experienced investors and other accountant
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
, financial analysts and companies looking to buy them in a major merger.
Does this ever make you think it is all a bunch of crapola? In my vi
Does this ever make you think it is all a bunch of crapola? In my vi
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
w and perception of the world, I only care about winning, show me. EBITDA, is such hokum, typical accounting crap. Look how much cash flow do y
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ou have, how much money did you make, real money. Everything else is a game play against reality and the created reality of government regulati
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
n and street expectations to keep the balloon aloft. In the end how much money, real money did you make, how much did you invest, re-invest in
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
the future of the company, pay to shareholders in cash and future growth of the company and therefore increase THEIR value, not anyone else's.
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
hat is the truth?
Often depreciations schedules are misleading because there is much that is depreciated that is still running fine and much,
Often depreciations schedules are misleading because there is much that is depreciated that is still running fine and much,
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
hich is not depreciated which is junk. For instance the retail sector product sellers, which depreciates shelf space fees of new products it br
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ings to market over 30 years? That is BS because there will be new products every 2-years, that ought to be expensed like most stock options. D
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
you find the whole thing utter BS, but, understand the accounting game is only about taxes and government regulations. It often seems utterly
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ridiculous. How can we blame companies from wanting to go offshore or become private again to bypass some of the over regulation?
We do not ne
We do not ne
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
d Sarbanes Oxley, we need less lawyers, lawsuits, crying petty one share minority shareholders with more power than God; starting class action
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
awsuits and storming the Shareholder meetings with dribble and crap. Do you ever thing we would be better off and Kill all the attorneys, dereg
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ulate some of this muck, so companies can get out of the sand trap, let companies survive on their reputations, investors beware, regulators go
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
screw their fellow workers over 1970s desks after they have filled themselves with taxpayer coffee? You would not be alone.
Maybe we could mov
Maybe we could mov
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
e DC to New-New Orleans and if the levees break again; well, "NO LOSS" those morons do not do anything anyway, which is just as well, but at le
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
st they could get out of the way, this concept also gives them free swimming lessons, which is fine as they are fat and will float. Think on it
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.subjects.org.ua/article/4465/subjects-Hiding-Behind-Numbers-in-Modern-Corporations.html">Hiding Behind Numbers in Modern Corporations</a>
BB link (for phorums):
[url=http://www.subjects.org.ua/article/4465/subjects-Hiding-Behind-Numbers-in-Modern-Corporations.html]Hiding Behind Numbers in Modern Corporations[/url]
Related Articles:
Growing Up - Not Growing Big - The Case for Keeping Your 5K Biz Small
Bookmark it:
|